al. 1) reported first 2 cases in 1965 were immunocompromised. A review by Brubaker 2) in 1983 also stated that TA-GVHD develops only in patients with cell-mediated immune deficiency.
Apart from these studies, in 1955, Shimoda 3) reported 12 cases of POE (postoperative erythroderma)
as a new disease that fell into severe condition with erythema on skin after surgical operation.
Among these 12 cases, 6 cases died, and 5 cases of them showed leucopenia. These cases seem to be TA-GVHD. However, we should pay attention because not all patients with POE are TA-GVHD. After the report by Shimoda, many cases of POE, especially those who received cardiovascular surgery were reported as serious condition with unknown mechanism in Japan. In 1984, Aoki et al. 4) conducted biopsy of the skin and bone marrow of a patient of POE after surgery of aortic aneurysm and found that lymphocyte-like cells bound and attacked the damaged cells in skin and bone marrow by histological examination. They reported that this condition was caused by GVHD. This report gave a strong impact on the researchers of surgery who had investigated POE, and the researchers in transfusion medicine because they were shocked by discovery of such serious side effect of transfusion.
They started to collect evidences that POE developed by the same mechanism of GVHD. Sakakibara et al. 5) showed presence of lymphocytes having HLA type different from that of the patient, in the peripheral blood of the patient with POE. Ito et al. 6) demonstrated that postoperative erythema in immunocompetent patients is one of symptoms of TA-GVHD, because the lymphocytes in the peripheral blood of a patient changed from HLA haplotype heterozygote (phenotype of the patient)
to homozygote (phenotype of the donor), when the patient had POE. This report demonstrates that TA-GVHD can develop in immunocompetent patients by one-way matching of HLA antigens.
Matsushita et al. Center, to elucidate its mechanism. This is a hemovigilance activity that starts from 1993 in Japan.
As mentioned above, 61 cases were confirmed by VNTR method as TA-GVHD, among more than 300 suspected cases of TA-GVHD , the data of which were collected in Japanese Hemovigilance
System from 1993 to 1999. No case was immunodeficient, except 1 case of SCID (severe combined immunodeficiency). This finding indicated that the guideline stipulating that irradiated blood should be used for immunodeficient patient, was not clinically relevant in Japan. After discussion with the Ministry of Health, Labour and Welfare, it was decided that blood products containing cells should be universally processed with irradiation after 2000. Fortunately, during these 10 years after the implementation of universal irradiation, no TA-GVHD occurred by blood supplied from Japanese Red Cross Blood Centers.
